David Griller
Director
Pharmaceuticals
verlyx
Canada
Biography
A co-founder of Oncozyme Pharma, which became Verlyx Pharma in 2015, Dr. Griller obtained his PhD in Chemistry in 1978 at University College London, UK. He worked for the National Research Council of Canada from 1975 to 1988 where he was the head of Organic Chemistry. He is the author or co-author of over 200 scientific publications and patents and has received a number of awards and medals for his research. He is a fellow of the Royal Society of Canada and of the Chemical Institute of Canada. Dr. Griller has also been extensively involved in management consulting. He worked for Deloitte Haskins and Sells in the UK and KPMG (Canada). He joined SECOR in 1991 and was a partner there until 2012. He is now managing partner of Genspark Consulting. Dr. Griller worked with Dr. Terry Chow to lay the foundations of Oncozyme Pharma. Working in close collaboration, they advanced Oncozyme’s technology from lab bench to human clinical trials and staked out the company’s core intellectual property position. Dr. Griller remains a board member, chair of the audit committee and an advisor to Verlyx’s management on scientific and intellectual property issues.
Research Interest
Human Clinical Trials,scientific and intellectual property issues.